USPTO serial 78343591
ACCREDO HEALTH GROUP
Reviewed by CopyMark Law Group
Reg. 3101585Status 710
- Filing date
- Status date
- Registration date
- Jun 6, 2006
- Examiner
- GARTNER, JOHN M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with ACCREDO HEALTH GROUP?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Grady M. Garrison
GRADY M. GARRISON Baker, Donelson, Bearman, Caldwell & Berkowitz, PC165 Madison Avenue, Suite 2000Memphis, TN 38103UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of chronic diseases, namely, alpha-1 antitrypsin deficiency, moderate to severe persistent asthma, pulmonary arterial hypertension, respiratory syncytial virus, chronic, moderate to severe plaque psoriasis, hereditary tyrosinemia type 1, autoimmune disorders and primary immune deficiencies, growth hormone deficiency, Fabry disease, rheumatoid arthritis, psoriatic arthritis, hemophilia, Gaucher disease, blepharospasm, cervical dystonia, hyperhidrosis, strabimus, multiple sclerosis, hypomobility associated with advanced Parkinson's disease, MPS 1, severe combined immunodeficiency disease, chronic granulomatour disease, severe malignant osterpetrosis; pharmaceutical preparations for use as blood clotting agents used in the control of hemophilia | SECTION 8 - CANCELLED | Jun 1, 2003 |
| 035 | Retail pharmacy services specializing in the control of chronic diseases; retail pharmacy services specializing in the control of hemophilia | SECTION 8 - CANCELLED | Jun 12, 2003 |
| 044 | Nursing care specializing in the treatment, prevention and control of chronic diseases; nursing care specializing in the treatment, prevention and control of hemophilia; medical services, namely, administration of pharmaceutical preparations used in the treatment of chronic diseases and administration of pharmaceutical preparations used in the treatment of hemophilia | SECTION 8 - CANCELLED | Apr 1, 2005 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Accredo Health Group, Inc.
- Other trademarks owned by Accredo Health Group, Inc.
- Other trademarks owned by Accredo Health Group, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 044
- Similar marks named ACCREDO HEALTH GROUP
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 11, 2013 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Sep 17, 2007 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 6, 2006 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 25, 2006 | REGV | LAW OFFICE REGISTRATION REVIEW COMPLETED | — |
| Apr 14, 2006 | ALIE | ASSIGNED TO LIE | — |
| Apr 10, 2006 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Mar 17, 2006 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Mar 2, 2006 | IUAF | USE AMENDMENT FILED | — |
| Mar 2, 2006 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Sep 6, 2005 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 14, 2005 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 25, 2005 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 3, 2005 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 1, 2005 | ALIE | ASSIGNED TO LIE | — |
| Feb 24, 2005 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 23, 2005 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Jan 20, 2005 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 20, 2005 | PAPER RECEIVED | — | |
| Jul 21, 2004 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 19, 2004 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 7, 2004 | NWAP | NEW APPLICATION ENTERED | — |